𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The development of novel HIV integrase inhibitors and the problem of drug resistance

✍ Scribed by Mark A Wainberg; Thibault Mesplède; Peter K Quashie

Book ID
118157821
Publisher
Elsevier
Year
2012
Tongue
English
Weight
307 KB
Volume
2
Category
Article
ISSN
1879-6257

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subtype diversity associated with the de
Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors
✍ Bluma G. Brenner; Matthew Lowe; Daniela Moisi; Isabelle Hardy; Simon Gagnon; Hug 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

## Abstract We used genotypic and phylogenetic analysis to determine integrase diversity among subtypes, and studied natural polymorphisms and mutations implicated in resistance to integrase inhibitors (INI) in treatment‐naïve persons (n = 220) and ‐experienced individuals (n = 24). Phylogenetics r

Development of the next generation of HI
Development of the next generation of HIV-1 integrase inhibitors: Pyrazolone as a novel inhibitor scaffold
✍ Victor Hadi; Yung-Hyo Koh; Tino Wilson Sanchez; Danielle Barrios; Nouri Neamati; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 522 KB

HIV-1 integrase (IN), one of the essential enzymes in HIV infection, has been validated as a target for HIV treatment. While more than 20 drugs have been approved by the FDA to treat HIV/AIDS, only one drug, Raltegravir (1), was approved as an IN inhibitor. The rapid mutation of the virus, which lea